PT99582A - Metodo de inibicao das interaccoes entre proteinas de adesao a celulas e hidratos de carbono - Google Patents
Metodo de inibicao das interaccoes entre proteinas de adesao a celulas e hidratos de carbono Download PDFInfo
- Publication number
- PT99582A PT99582A PT99582A PT9958291A PT99582A PT 99582 A PT99582 A PT 99582A PT 99582 A PT99582 A PT 99582A PT 9958291 A PT9958291 A PT 9958291A PT 99582 A PT99582 A PT 99582A
- Authority
- PT
- Portugal
- Prior art keywords
- cell
- protein
- antibody
- elam
- sialyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/972—Modified antibody, e.g. hybrid, bifunctional
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61831490A | 1990-11-23 | 1990-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT99582A true PT99582A (pt) | 1992-10-30 |
Family
ID=24477202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99582A PT99582A (pt) | 1990-11-23 | 1991-11-22 | Metodo de inibicao das interaccoes entre proteinas de adesao a celulas e hidratos de carbono |
Country Status (16)
Country | Link |
---|---|
US (5) | US5801044A (xx) |
EP (1) | EP0640129A1 (xx) |
JP (2) | JPH06504619A (xx) |
AU (1) | AU656934B2 (xx) |
BR (1) | BR9106995A (xx) |
CA (1) | CA2097617A1 (xx) |
CZ (1) | CZ96893A3 (xx) |
FI (1) | FI932336A0 (xx) |
HU (1) | HUT64476A (xx) |
IE (1) | IE914075A1 (xx) |
IL (1) | IL100094A0 (xx) |
MC (1) | MC2324A1 (xx) |
NO (1) | NO931864L (xx) |
NZ (1) | NZ240646A (xx) |
PT (1) | PT99582A (xx) |
WO (1) | WO1992009293A1 (xx) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6387884B1 (en) * | 1990-06-18 | 2002-05-14 | Stanford University | Leukocyte homing modulation |
US6391857B1 (en) * | 1990-06-18 | 2002-05-21 | Stanford University | Methods and compositions for endothelial binding |
CZ96893A3 (en) * | 1990-11-23 | 1993-12-15 | Gen Hospital Corp | Inhibition of adhesive protein cells and their carbohydrates interaction |
US5807745A (en) * | 1991-03-11 | 1998-09-15 | New England Medical Center Hospitals, Inc. | Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component |
US6121233A (en) * | 1991-04-19 | 2000-09-19 | John L. Magnani | Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
US5646123A (en) * | 1991-06-10 | 1997-07-08 | Alberta Research Council | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
EP0521692A3 (en) * | 1991-07-02 | 1993-02-03 | The Biomembrane Institute | Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
US5648458A (en) * | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
US5643873A (en) * | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
US5728802A (en) * | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
WO1994007517A1 (en) | 1992-10-02 | 1994-04-14 | Alberta Research Council | Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
US5453272A (en) * | 1992-10-02 | 1995-09-26 | Alberta Research Council | Lectin derived carbohydrate binding-peptide |
US5750508A (en) * | 1993-06-16 | 1998-05-12 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5837689A (en) * | 1993-06-16 | 1998-11-17 | Glycomed Incorporated | Sialyl lewis-x mimetics containing naphthyl backbones |
US5789385A (en) * | 1993-06-16 | 1998-08-04 | Glycomed Incorporated | Sialyl Lewisx mimetics containing phenyl backbones |
US5658880A (en) * | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5679321A (en) * | 1993-06-17 | 1997-10-21 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US7399847B1 (en) * | 1996-11-25 | 2008-07-15 | The General Hospital Corporation | Nucleic acids encoding artificial P-selectin ligands |
US6610485B1 (en) * | 1998-05-20 | 2003-08-26 | Chugai Seiyaku Kabushiki Kaisha | Methods for isolating a cDNA encoding a membrane-bound protein |
ES2568899T3 (es) * | 1999-04-09 | 2016-05-05 | Kyowa Hakko Kirin Co., Ltd. | Procedimiento para controlar la actividad de una molécula inmunofuncional |
US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
EP1438387A4 (en) * | 2001-09-14 | 2004-10-13 | Momenta Pharmaceuticals Inc | METHODS OF MAKING GLYCOMOLECULES WITH IMPROVED ACTIVITY, AND USES THEREOF |
WO2003047623A1 (en) * | 2001-10-11 | 2003-06-12 | Protein Design Labs Inc. | Treatment of prostate cancer by inhibitors of ncam2 |
US7691568B2 (en) | 2002-04-09 | 2010-04-06 | Kyowa Hakko Kirin Co., Ltd | Antibody composition-containing medicament |
JP5183010B2 (ja) | 2002-05-16 | 2013-04-17 | グリコミメティクス, インコーポレイテッド | セレクチンによって媒介される機能を阻害するための化合物および方法 |
AU2003245595A1 (en) * | 2002-07-03 | 2004-01-23 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
US20050226867A1 (en) * | 2003-10-08 | 2005-10-13 | Kyowa Hakko Kogyo Co., Ltd. | IL-5R-specific antibody composition |
US20050287138A1 (en) * | 2003-10-08 | 2005-12-29 | Kyowa Hakko Kogyo Co., Ltd. | CCR4-specific antibody composition |
US20060021071A1 (en) * | 2003-10-09 | 2006-01-26 | Kyowa Hakko Kogyo Co., Ltd. | Cell in which genome is modified |
AU2004280064A1 (en) * | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Genomically modified cell neutralized to serum-free system |
US7691810B2 (en) * | 2003-10-09 | 2010-04-06 | Kyowa Hakko Kirin Co., Ltd | Method of producing recombinant antithrombin III composition |
JP2007524658A (ja) * | 2003-11-19 | 2007-08-30 | グリコミメティクス, インコーポレイテッド | E−およびp−セレクチンの両方のための糖模倣物アンタゴニスト |
DE602004011272T2 (de) * | 2003-11-19 | 2008-12-24 | Glycomimetics, Inc. | Spezifischer antagonist sowohl für e- als auch p-selektine |
US8201377B2 (en) * | 2004-11-05 | 2012-06-19 | Faus Group, Inc. | Flooring system having multiple alignment points |
FR2886298A1 (fr) * | 2005-05-24 | 2006-12-01 | Ifremer | Anticorps ou fragment d'anticorps couple a un agent immunogene |
US20090036386A1 (en) * | 2005-05-25 | 2009-02-05 | Glycomimetics, Inc | Heterobifunctional compounds for selectin inhibition |
US7517980B2 (en) * | 2005-08-09 | 2009-04-14 | Glycomimetics, Inc. | Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas |
EP2264043B1 (en) * | 2005-09-02 | 2017-11-08 | GlycoMimetics, Inc. | Heterobifunctional pan-selectin inhibitors |
US8470318B2 (en) * | 2005-11-07 | 2013-06-25 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
AU2006312148B2 (en) * | 2005-11-07 | 2012-04-12 | The Rockefeller University | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
US20080206246A1 (en) * | 2006-04-05 | 2008-08-28 | Ravetch Jeffrey V | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
US20070161546A1 (en) * | 2005-12-15 | 2007-07-12 | Colm King | Methods and compositions for treatment of cancer |
US20110014270A1 (en) * | 2006-03-27 | 2011-01-20 | The Regents Of The University Of Colorado | Prevention and treatment of ischemia-reperfusion injury and related conditions |
CN101432301B (zh) * | 2006-04-05 | 2014-01-08 | 洛克菲勒大学 | 具有增强的抗炎性和降低的细胞毒性特性的多肽以及相关方法 |
WO2007143052A1 (en) * | 2006-06-01 | 2007-12-13 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
WO2008060378A2 (en) | 2006-10-12 | 2008-05-22 | Glycomimetics, Inc. | Glycomimetic replacements for hexoses and n-acetyl hexosamines |
JP5511390B2 (ja) * | 2007-02-09 | 2014-06-04 | グリコミメティクス, インコーポレイテッド | ヘキソースおよびn−アセチルヘキソサミンの置換体を有する糖模倣体の使用方法 |
US8039442B2 (en) * | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
US20110150867A1 (en) * | 2007-12-14 | 2011-06-23 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
AU2009240637A1 (en) * | 2008-04-22 | 2009-10-29 | The Rockefeller University | Methods of identifying anti-inflammatory compounds |
WO2009152245A1 (en) * | 2008-06-13 | 2009-12-17 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
CN102421441B (zh) * | 2009-05-01 | 2015-04-01 | 糖模拟物有限公司 | E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂 |
CN101921336B (zh) * | 2009-06-11 | 2013-02-27 | 北京华大蛋白质研发中心有限公司 | 一种抗人α1酸性糖蛋白的单克隆抗体及其制备方法 |
AU2011237442A1 (en) | 2010-04-07 | 2012-10-18 | Momenta Pharmaceuticals, Inc. | High mannose glycans |
AU2011258425B2 (en) | 2010-05-27 | 2015-12-10 | Merck Sharp & Dohme Llc | Method for preparing antibodies having improved properties |
WO2012037034A1 (en) | 2010-09-14 | 2012-03-22 | Glycomimetics, Inc. | E-selectin antagonists |
EP2686671A4 (en) | 2011-03-12 | 2015-06-24 | Momenta Pharmaceuticals Inc | N-GLYCANES CONTAINING N-ACETYLHEXOSAMINE IN GLYCOPROTEIN PRODUCTS |
CN103582650A (zh) | 2011-05-25 | 2014-02-12 | 默沙东公司 | 用于制备具有改善性质的含Fc多肽的方法 |
WO2013096926A1 (en) | 2011-12-22 | 2013-06-27 | Glycomimetics, Inc. | E-selectin antagonist compounds, compositions, and methods of use |
US9695244B2 (en) | 2012-06-01 | 2017-07-04 | Momenta Pharmaceuticals, Inc. | Methods related to denosumab |
EP2928476B1 (en) | 2012-12-07 | 2018-02-14 | GlycoMimetics, Inc. | Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells |
WO2014149067A1 (en) | 2013-03-15 | 2014-09-25 | Momenta Pharmaceuticals, Inc. | Methods related to ctla4-fc fusion proteins |
WO2014186310A1 (en) | 2013-05-13 | 2014-11-20 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
ES2754549T3 (es) | 2014-12-03 | 2020-04-20 | Glycomimetics Inc | Inhibidores heterobifuncionales de E-selectinas y receptores de quimioquinas CXCR4 |
WO2017127422A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
EP3497131B1 (en) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4. |
US11072625B2 (en) | 2016-10-07 | 2021-07-27 | Glycomimetics, Inc. | Highly potent multimeric e-selectin antagonists |
WO2018169853A1 (en) | 2017-03-15 | 2018-09-20 | Glycomimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
EP3717013A1 (en) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
EP3732186A1 (en) | 2017-12-29 | 2020-11-04 | GlycoMimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
CN111867601A (zh) | 2018-03-05 | 2020-10-30 | 糖模拟物有限公司 | 用于治疗急性髓系白血病及相关病症的方法 |
WO2020139962A1 (en) | 2018-12-27 | 2020-07-02 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
CA3168704A1 (en) | 2020-01-24 | 2021-07-29 | Pfizer Inc. | Anti-e-selectin antibodies, compositions and methods of use |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4184917A (en) * | 1974-04-01 | 1980-01-22 | Sandoz Ltd. | Process for producing a structurally modified interferon |
DE2621908A1 (de) * | 1975-05-26 | 1976-12-09 | Sandoz Ag | Neues diagnostikum fuer maligne tumore |
JPS53136586A (en) * | 1977-05-02 | 1978-11-29 | Ajinomoto Co Inc | Preparation of llglutamic acidd*c* semialdehyde |
DE2846412A1 (de) * | 1978-10-25 | 1980-05-08 | Behringwerke Ag | Mittel zur behandlung allergischer reaktionen |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
JPS60123494A (ja) * | 1983-12-08 | 1985-07-02 | Rikagaku Kenkyusho | シアル酸含有オリゴ糖およびその製造法 |
US4752569A (en) * | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
JPS6283898A (ja) * | 1985-10-09 | 1987-04-17 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト肺腺癌特異的単クロ−ン性抗体 |
US4851511A (en) * | 1986-01-30 | 1989-07-25 | Fred Hutchinson Cancer Research Center | Monoclonal antibody that specifically binds to disialosyl Lea |
US5057313A (en) * | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
JPS63152393A (ja) * | 1986-07-03 | 1988-06-24 | Takeda Chem Ind Ltd | グリコシル誘導体 |
US4840793A (en) * | 1987-06-11 | 1989-06-20 | Dana-Farber Cancer Institute | Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
ES2064327T3 (es) * | 1987-11-02 | 1995-02-01 | Baylor College Medicine | Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica. |
SE464687B (sv) * | 1987-11-10 | 1991-06-03 | Biocarb Ab | Foerfarande foer framstaellning av en gelprodukt |
US5079353A (en) * | 1987-12-02 | 1992-01-07 | Chembiomed, Ltd. | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
EP0323802A3 (en) * | 1987-12-24 | 1989-07-26 | Sandoz Ag | Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
CA1340587C (en) * | 1988-03-11 | 1999-06-08 | Thomas J. Kjeldsen | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
US5081034A (en) * | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
AU636589B2 (en) * | 1988-11-14 | 1993-05-06 | Brigham And Women's Hospital | Antibodies specific for elam-1 and the use thereof |
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
FR2654876B1 (fr) * | 1989-11-23 | 1993-11-12 | Commissariat A Energie Atomique | Dispositif de charge de moyens d'accumulation d'energie electrique, muni de moyens permettant de maitriser cette charge. |
JPH05501359A (ja) * | 1990-04-27 | 1993-03-18 | バイオジェン,インコーポレイテッド | 付着分子発現に関与するフコシルトランスフェラーゼ |
US5211937A (en) * | 1990-07-30 | 1993-05-18 | Glycomed Incorporated | Method of determining a site of inflammation utilizing elam-1 ligands |
US5143712A (en) * | 1990-07-30 | 1992-09-01 | Glycomed Incorporated | Method of determining a site of inflammation utilizing elam-1 ligands |
US5211936A (en) * | 1990-07-30 | 1993-05-18 | Glycomed Incorporated | Method of determining a cite of inflammation utilizing elam-1 ligands site |
CZ96893A3 (en) * | 1990-11-23 | 1993-12-15 | Gen Hospital Corp | Inhibition of adhesive protein cells and their carbohydrates interaction |
ATE338762T1 (de) * | 1991-04-19 | 2006-09-15 | Univ Leland Stanford Junior | Zusammensetzungen und methoden für die verknüpfung von endothelzellen |
US5443953A (en) * | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
-
1991
- 1991-11-18 CZ CZ93968A patent/CZ96893A3/cs unknown
- 1991-11-18 AU AU90618/91A patent/AU656934B2/en not_active Ceased
- 1991-11-18 CA CA002097617A patent/CA2097617A1/en not_active Abandoned
- 1991-11-18 IE IE407591A patent/IE914075A1/en unknown
- 1991-11-18 MC MC912324A patent/MC2324A1/xx unknown
- 1991-11-18 JP JP4502313A patent/JPH06504619A/ja active Pending
- 1991-11-18 WO PCT/US1991/008605 patent/WO1992009293A1/en not_active Application Discontinuation
- 1991-11-18 NZ NZ240646A patent/NZ240646A/en unknown
- 1991-11-18 BR BR919106995A patent/BR9106995A/pt unknown
- 1991-11-18 HU HU9301510A patent/HUT64476A/hu unknown
- 1991-11-18 EP EP92901221A patent/EP0640129A1/en not_active Withdrawn
- 1991-11-20 IL IL100094A patent/IL100094A0/xx unknown
- 1991-11-22 PT PT99582A patent/PT99582A/pt not_active Application Discontinuation
-
1993
- 1993-05-21 NO NO93931864A patent/NO931864L/no unknown
- 1993-05-21 FI FI932336A patent/FI932336A0/fi not_active Application Discontinuation
-
1995
- 1995-06-05 US US08/461,968 patent/US5801044A/en not_active Expired - Lifetime
- 1995-06-05 US US08/462,571 patent/US5858983A/en not_active Expired - Lifetime
- 1995-06-07 US US08/472,888 patent/US6613746B1/en not_active Expired - Fee Related
- 1995-06-07 US US08/480,036 patent/US5723583A/en not_active Expired - Lifetime
-
1999
- 1999-01-12 US US09/229,030 patent/US6156881A/en not_active Expired - Fee Related
-
2000
- 2000-04-04 JP JP2000102880A patent/JP2000325092A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ240646A (en) | 1994-01-26 |
CZ96893A3 (en) | 1993-12-15 |
AU9061891A (en) | 1992-06-25 |
JP2000325092A (ja) | 2000-11-28 |
NO931864L (no) | 1993-07-21 |
IE914075A1 (en) | 1992-06-03 |
FI932336A (fi) | 1993-05-21 |
FI932336A0 (fi) | 1993-05-21 |
US5723583A (en) | 1998-03-03 |
CA2097617A1 (en) | 1992-05-23 |
US5801044A (en) | 1998-09-01 |
MC2324A1 (fr) | 1994-01-18 |
BR9106995A (pt) | 1993-08-24 |
IL100094A0 (en) | 1992-08-18 |
US6613746B1 (en) | 2003-09-02 |
AU656934B2 (en) | 1995-02-23 |
JPH06504619A (ja) | 1994-05-26 |
HU9301510D0 (en) | 1993-10-28 |
HUT64476A (en) | 1994-01-28 |
NO931864D0 (no) | 1993-05-21 |
EP0640129A1 (en) | 1995-03-01 |
EP0640129A4 (en) | 1994-07-05 |
US6156881A (en) | 2000-12-05 |
WO1992009293A1 (en) | 1992-06-11 |
US5858983A (en) | 1999-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT99582A (pt) | Metodo de inibicao das interaccoes entre proteinas de adesao a celulas e hidratos de carbono | |
Aigner et al. | Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin | |
Gyotoku et al. | Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. | |
AU658383B2 (en) | Agents and methods for binding to elam-1 | |
JP3541296B2 (ja) | 腫瘍血管内皮細胞に特異的に結合するモノクローナル抗体とその利用方法 | |
US6465434B1 (en) | Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules | |
EP1396542B1 (en) | P-Selectin Ligand Protein | |
EP0580763A1 (en) | Compositions and methods for endothelial binding | |
KR20040039440A (ko) | 셀렉틴 매개 염증의 펩티드 및 o-글리칸 억제제 | |
US5440015A (en) | Selectin peptide medicaments for treating disease | |
DE69431167T2 (de) | Verfahren zum selektiven methioninentzug für maligne säugetierzellen | |
US5648465A (en) | Cloning and expression of neurocan, a chondroitin sulfate proteoglycan | |
US5659018A (en) | Mocarhagin, a cobra venom protease, and therapeutic uses thereof | |
WO1994003601A9 (en) | Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan | |
JPH11508131A (ja) | P−セレクチンリガンドおよび関連分子並びに方法 | |
ES2362695T3 (es) | Nueva proteína del ligando de la p-selectina. | |
Larue et al. | Optimization of mouse IgG fragmentation technique in the selection of monoclonal antibodies for myocardial infarct imaging | |
Gbarah | Studies on the mechanism of lectinophagocytosis of mannose specific bacteria | |
Kim | Pathophysiological roles of selectins in colon carcinoma biology | |
NZ299428A (en) | Liposome with sialyl lewis x determinant on its surface that binds elam-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920601 |
|
FC3A | Refusal |
Effective date: 19990205 |